In United States market
Ajanta Pharma USA Inc., a subsidiary of Ajanta Pharma, has launched Montelukast Sodium IR Tablets (10mg) and Montelukast Sodium Chewable Tablets (4mg & 5mg), generic versions of SINGULAIR Tablets and SINGULAIR Chewable Tablets, respectively.The United States Food & Drug Administration (US FDA) approval extends the breadth of the Montelukast offerings from Ajanta Pharma into three dosage forms (Immediate-Release Tablets, Chewable Tablets, and Oral Granules).
Montelukast IR Tablets and Chewable Tablets are part of an ever-growing portfolio that Ajanta Pharma has developed for the US market.
Powered by Capital Market - Live News